These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18654454)

  • 1. Basic instincts.
    Nat Nanotechnol; 2008 Feb; 3(2):59. PubMed ID: 18654454
    [No Abstract]   [Full Text] [Related]  

  • 2. Why French politics and science don't mix.
    Nat Mater; 2004 May; 3(5):275. PubMed ID: 15122212
    [No Abstract]   [Full Text] [Related]  

  • 3. Little science, big bucks.
    DeFrancesco L
    Nat Biotechnol; 2003 Oct; 21(10):1127-9. PubMed ID: 14520387
    [No Abstract]   [Full Text] [Related]  

  • 4. Federal stimulus adds momentum to sequencing stampede.
    Fox JL
    Nat Biotechnol; 2009 Dec; 27(12):1061-2. PubMed ID: 20010558
    [No Abstract]   [Full Text] [Related]  

  • 5. World view: Save British science, again.
    Macilwain C
    Nature; 2010 Sep; 467(7313):269. PubMed ID: 20844513
    [No Abstract]   [Full Text] [Related]  

  • 6. Challenges for a champion.
    Nat Nanotechnol; 2007 Mar; 2(3):129. PubMed ID: 18654233
    [No Abstract]   [Full Text] [Related]  

  • 7. Oh no! Not another acronym?
    Wallner PE
    J Am Coll Radiol; 2004 Sep; 1(9):629. PubMed ID: 17411670
    [No Abstract]   [Full Text] [Related]  

  • 8. Brussels backs nanotech.
    Nat Nanotechnol; 2007 Feb; 2(2):65. PubMed ID: 18654212
    [No Abstract]   [Full Text] [Related]  

  • 9. Italian science: greater expectations?
    Gambardella P
    Nat Mater; 2006 Oct; 5(10):757. PubMed ID: 17013400
    [No Abstract]   [Full Text] [Related]  

  • 10. Reform science? First, reset the economy.
    Rosei F
    Nat Mater; 2006 Oct; 5(10):757-8. PubMed ID: 17013399
    [No Abstract]   [Full Text] [Related]  

  • 11. Benefits of biotech clusters questioned.
    Sheridan C
    Nat Biotechnol; 2003 Nov; 21(11):1258-9. PubMed ID: 14595343
    [No Abstract]   [Full Text] [Related]  

  • 12. Germany biotech gets second chance.
    Sheridan C
    Nat Biotechnol; 2003 Dec; 21(12):1414-5. PubMed ID: 14647310
    [No Abstract]   [Full Text] [Related]  

  • 13. Flat NIH funding threatens scientific progress.
    J Nucl Med; 2007 May; 48(5):15N, 22N. PubMed ID: 17475944
    [No Abstract]   [Full Text] [Related]  

  • 14. Science and politics: a fatal mix?
    Joachim C
    Nat Mater; 2004 Jul; 3(7):416. PubMed ID: 15229483
    [No Abstract]   [Full Text] [Related]  

  • 15. Small world, big hopes.
    Watanabe M
    Nat Mater; 2004 Jan; 3(1):73-4. PubMed ID: 14704788
    [No Abstract]   [Full Text] [Related]  

  • 16. Scottish science is ready to go it alone.
    Macilwain C
    Nature; 2013 Jan; 493(7434):579. PubMed ID: 23364703
    [No Abstract]   [Full Text] [Related]  

  • 17. Biotech parks proliferate, despite concerns over sustainability.
    Jia H; Jayaraman KS; Orellana C
    Nat Biotechnol; 2003 Nov; 21(11):1259-60. PubMed ID: 14595344
    [No Abstract]   [Full Text] [Related]  

  • 18. More than the sum of their parts? Clustering is becoming more prevalent in the biosciences, despite concerns over the sustainability and economic effectiveness of science parks and hubs.
    Rinaldi A
    EMBO Rep; 2006 Feb; 7(2):133-6. PubMed ID: 16452923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New competition in Germany.
    Nat Neurosci; 2006 Jun; 9(6):711. PubMed ID: 16732195
    [No Abstract]   [Full Text] [Related]  

  • 20. Increasing number of companies found ineligible for SBIR funding.
    Bouchie A
    Nat Biotechnol; 2003 Oct; 21(10):1121-2. PubMed ID: 14520384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.